Congratulations to TPS Board Members Dr. Miles Day & Dr. Larry Driver!
On May 4, 2019, during the 2019 ASIPP Annual Conference Drs. Day & Driver were presented with awards.
Dr. Day (pictured above) received the 2019 Raj Excellence Award and Dr. Larry Driver (pictured below) received the 2019 Racz Excellence Award!
Some policies, practices attributed to the Guideline are inconsistent with its recommendations
Embargoed Until: Wednesday, April 24, 2019, 5 PM, EDT
Contact: Media Relations
(404) 639-3286
Mark Your Calendars and Plan to Attend the Texas Pain Society Lectures During TexMed 2019
Date: Friday, May 17, 2019
Location: Hilton Anatole Hotel, Dallas, Texas - West Wing, Coronado A
Time: 7:3oam - 11:30am
Pain Medicine Program Agenda
7:30 AM: Welcome and Introductions
7:30 AM: (ETHICS) Primary Care Pain Medicine: State-of-the-Art 2019
Presented by Brian Bruel, MD, Director, Pain Medicine, Baylor College of Medicine, Houston
8:00 AM: (ETHICS) Texas Medical Board Updates & Top 50 Pitfalls
Presented by Sherif Zafraan, MD, President, Texas Medical Board, Houston
On April 27, 2019 at 10:00 AM
The National Prescription Drug Take Back Day addresses a crucial public safety and public health issue. According to the 2017 National Survey on Drug Use and Health, 6 million Americans misused controlled prescription drugs. The study shows that a majority of abused prescription drugs were obtained from family and friends, often from the home medicine cabinet.
US warns docs not to abruptly halt opioid pain treatment
April 9, 2019
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials Tuesday, April 9. 2019, warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches. (AP Photo/Mark Lennihan, File)
WASHINGTON (AP) — U.S. health officials Tuesday warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches.
April 9, 2019
The Centers for Disease Control and Prevention (CDC) issued a key clarification on its Guideline for Prescribing Opioids for Chronic Pain. The clarification comes as a result of a collaborative effort by ASCO, the American Society of Hematology (ASH), CDC, and the National Comprehensive Cancer Network (NCCN) to clarify CDC’s opioid prescribing guideline to ensure appropriate implementation for people with cancer, cancer survivors, and patients with sickle cell disease.
The aims and objectives of the Foundation are to advance the art and science of pain medicine in Texas.
